IRIS
TONIUTTO, Pierluigi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.279
AS - Asia 6.939
EU - Europa 4.654
SA - Sud America 1.259
AF - Africa 160
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 5
Totale 29.318
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.016
SG - Singapore 3.458
CN - Cina 1.327
UA - Ucraina 1.059
BR - Brasile 986
DE - Germania 819
HK - Hong Kong 692
IT - Italia 478
VN - Vietnam 476
FR - Francia 444
FI - Finlandia 420
RU - Federazione Russa 359
SE - Svezia 327
TR - Turchia 245
IE - Irlanda 242
GB - Regno Unito 196
IN - India 166
CA - Canada 139
AR - Argentina 107
KR - Corea 101
BD - Bangladesh 80
MX - Messico 80
IQ - Iraq 65
PL - Polonia 57
ZA - Sudafrica 47
BE - Belgio 46
EC - Ecuador 42
JP - Giappone 42
IR - Iran 39
PK - Pakistan 38
ID - Indonesia 37
AT - Austria 36
CO - Colombia 36
ES - Italia 34
NL - Olanda 33
UZ - Uzbekistan 24
VE - Venezuela 24
PH - Filippine 23
PY - Paraguay 23
MA - Marocco 22
SA - Arabia Saudita 20
EU - Europa 19
CL - Cile 18
KE - Kenya 16
CZ - Repubblica Ceca 15
LT - Lituania 13
AE - Emirati Arabi Uniti 11
DZ - Algeria 11
AZ - Azerbaigian 10
CH - Svizzera 10
ET - Etiopia 10
PE - Perù 10
EG - Egitto 9
TG - Togo 9
TN - Tunisia 9
GR - Grecia 8
AL - Albania 7
DO - Repubblica Dominicana 7
JO - Giordania 7
NP - Nepal 7
AO - Angola 6
BO - Bolivia 6
HN - Honduras 6
BH - Bahrain 5
DK - Danimarca 5
EE - Estonia 5
HU - Ungheria 5
LB - Libano 5
MY - Malesia 5
NI - Nicaragua 5
PA - Panama 5
PS - Palestinian Territory 5
SN - Senegal 5
TW - Taiwan 5
HR - Croazia 4
JM - Giamaica 4
KG - Kirghizistan 4
KW - Kuwait 4
LK - Sri Lanka 4
LV - Lettonia 4
OM - Oman 4
QA - Qatar 4
RO - Romania 4
UY - Uruguay 4
AM - Armenia 3
AU - Australia 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BN - Brunei Darussalam 3
CR - Costa Rica 3
IL - Israele 3
KZ - Kazakistan 3
LI - Liechtenstein 3
NO - Norvegia 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
BF - Burkina Faso 2
Totale 29.270
Salva come PNG Salva come JPEG
Città #
Fairfield 1.862
Woodbridge 1.800
Ashburn 1.400
Singapore 1.372
Ann Arbor 1.043
Houston 1.018
Chandler 1.002
Seattle 768
Wilmington 737
Jacksonville 705
Hong Kong 688
Cambridge 637
Beijing 577
Dearborn 463
San Jose 400
Boardman 312
Lauterbourg 231
Princeton 229
Dublin 228
Udine 228
Munich 226
Los Angeles 223
Izmir 175
Ho Chi Minh City 165
Helsinki 157
Hefei 119
New York 103
Hanoi 101
Dallas 99
Buffalo 93
São Paulo 90
San Diego 88
Seoul 86
Redondo Beach 85
The Dalles 76
Ottawa 67
Council Bluffs 56
Des Moines 54
Warsaw 48
Nuremberg 47
Mumbai 45
Brussels 40
Tokyo 39
Frankfurt am Main 38
Santa Clara 36
Mexico City 35
Norwalk 35
Kunming 34
Ogden 34
Orem 32
Baghdad 30
Falls Church 30
Rio de Janeiro 30
Shanghai 29
Nanjing 28
Montreal 27
Da Nang 25
Denver 25
Leawood 25
Phoenix 25
Guangzhou 23
Brooklyn 22
Chennai 22
Johannesburg 22
San Francisco 22
Chicago 21
Dong Ket 21
Stockholm 21
Vienna 21
Atlanta 19
Toronto 19
Amsterdam 18
London 18
Tashkent 18
Trieste 18
Düsseldorf 17
San Mateo 17
Washington 16
Zanjan 16
Belo Horizonte 15
Chongqing 15
Dhaka 15
Jinan 15
Manchester 14
Nairobi 14
Poplar 14
Quito 14
Zhengzhou 14
Augusta 13
Lahore 13
Milan 13
Turku 13
Ankara 12
Belluno 12
Guarulhos 12
Haiphong 12
Hangzhou 12
Istanbul 12
Asunción 11
Boston 11
Totale 19.147
Salva come PNG Salva come JPEG
Nome #
Interleukin 6 promoter polymorphisms influence the outcome of chronic hepatitis C. 252
Deficient antithrombin III activity and enhanced fibrinolysis in patients with liver disease: Evidence against a cause-effect relationship 244
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. 234
Increase of Serum aú1-Acid Glycoprotein Despite the Decline of Liver Synthetic Function in Cirrhotics with Hepatocellular Carcinoma 230
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 230
A single-center experience of late retransplantation of the liver. 229
Steatosis of the graft is a risk factor for posttransplantation biliary complications. 223
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 219
Skills and requirements of a transplant hepatologist: board certification of the Italian Association for the Study of the Liver (AISF). 216
Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C 210
Association between the epidermal growth factor rs4444903 G/G genotype and advanced fibrosis at a young age in chronic hepatitis C. 207
LONG-TERM OUTCOMES OF ORTHOTOPIC LIVER TRANSPLANTATION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS AND COMPARISON WITH HUMAN IMMUNODEFICIENCY VIRUS-NEGATIVE CASES 200
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: Evidence from the Liver Match cohort study 198
PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis 192
Apolipoprotein E genotypes modulate fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases. 190
Management of infections in cirrhotic patients: report of a consensus conference. 189
Liver transplantation from old donors into HCV and non-HCV recipients 189
Intensity of inflammatory damage and serum lipid peroxide concentrations in liver disease 186
Early activation of interferon-stimulated genes in human liver allografts: relationship with acute rejection and histological outcome. 184
A comparison of four serum markers of fibrosis in the diagnosis of cirrhosis 181
Association between vitamin D receptor genetic polymorphisms and acute cellular rejection in liver-transplanted patients. 180
Toll Like Receptor 4 D299G Associates with Disease Progression in Caucasian Patients with Chronic HBV Infection: Relationship with Gender. 179
The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases. 176
Serum soluble vascular-cell adhesion molecule-1 (VCAM-1) in patients with acute and chronic liver diseases 176
Clinical and virologic response to entecavir in HBV related chronic hepatitis or cirrhosis: data from the clinical practice in a single centre cohort. 175
Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma. 174
Pegylated versus standard interferon-alpha in antiviral regimens for post-transplant recurrent hepatitis C: Comparison of tolerability and efficacy 174
Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype. 173
DE NOVO TUMORS ARE A MAJOR CAUSE OF LATE MORTALITY AFTER ORTHOTOPIC LIVER TRANSPLANTATION 169
Changes in blood lipid composition and response to interferon treatment in chronic hepatitis C 167
Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis C. 166
Mild sialoadenitis: a common finding in patients with hepatitis C virus infection 166
Circulating intercellular adhesion molecule-1 (cICAM-1) concentration in liver disease. Relationship with cholestasis and functioning hepatic mass. 166
Degree of bile-duct dilatation in liver-transplanted patients with biliary stricture: a magnetic resonance cholangiography-based study. 165
A study on role of the family and other risk factors in HCV transmission 165
Biliary strictures after liver transplantation: Role of interleukin 28B genotypes in cyclosporine treated 164
Low fibrosis progression of recurrent hepatitis C in apolipoprotein E e4 carriers: relationship with the blood lipid profile 163
Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts. 162
INFLUENCE OF ANGIOTENSIN-CONVERTING ENZYME I/D GENE POLYMORPHISM ON CLINICAL AND HISTOLOGICAL CORRELATES OF CHRONIC HEPATITIS C 162
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients. 161
STEATOSIS OF THE HEPATIC GRAFT AS A RISK FACTOR FOR POST-TRANSPLANT BILIARY COMPLICATIONS 161
Specific issues concerning the management of patients on the waiting list and after liver transplantation 161
Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients 161
Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C 160
Splenic Artery Syndrome as a Possible Cause of Late Onset Refractory Ascites after Liver Transplantation: Management with Proximal Splenic Artery Embolization 159
Weight gain after liver transplantation and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene 158
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial 158
Impact of magnetic resonance cholangiography in managing liver-transplanted patients: preliminary results of a clinical decision-making study 156
Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation. 155
DIFFUSION-WEIGHTED MRI IN EVALUATING LIVER FIBROSIS: A FEASIBILITY STUDY IN CIRRHOTIC PATIENTS 155
GENE POLYMORPHISM AT THE INTERLEUKIN 6 -174 G > C LOCUS AFFECTS THE OUTCOME OF CHRONIC HEPATITIS B 154
Quality-of-life assessment before and after liver transplantation. 154
Consensus conference on TIPS management: Techniques, indications, contraindications 154
Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: A 5-year experience 154
Acute alcoholic hepatitis and liver transplantation: Waiting for Godot 153
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. 153
Occult hepatitis B virus infection in peripheral blood mononuclear cells among treatment-naive patients with chronic lymphocytic leukemia. 153
Hepatic release of erythropoietin induced by transarterial chemoembolization in patients with hepatocellular carcinoma. 152
Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation 152
OCCULT HEPATITIS B VIRUS INFECTION IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C: RELATIONSHIP WITH DONOR AGE AND FIBROSIS PROGRESSION 151
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 150
Favourable Outcome of Adefovir-Dipivoxil Treatment in Acute de Novo Hepatitis B After Liver Transplantation 150
Anti-envelope antibodies in anti-hepatitis C virus (HCV) positive patients with and without liver disease 150
Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C. 149
Prevalence and risk factors for delayed adrenal insufficiency after liver transplantation 149
Evidence for a multifactorial control of serum erythropoietin concentration in liver disease 149
Thrombocytopenia of chronic liver disease corrected by erythropoietin treatment 147
Recipient interleukin-28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: role of the calcineurin inhibitor used. 146
Recipient perioperative cholesterolaemia and graft cholesterol metabolism gene expression predict liver transplant outcome. 146
Diagnostic usefulness of acute-phase protein measurement in hepatocellular carcinoma. 146
Chronic sialoadenitis associated with HCV-related liver disease: differences in comparison to Sjogren syndrome 146
Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases 145
Interleukin-6 polymorphisms and gender: relationship with the occurrence of hepatocellular carcinoma in patients with end stage liver disease 145
Vitamin A deficiency is associated with hepatitis C virus chronic infection and with unresponsiveness to interferon-based antiviral therapy. 144
Predictors of endoscopic treatment outcome in the management of biliary complications after orthotopic liver transplantation 144
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 144
Carriage of the EGF rs4444903 A>G functional polymorphism associates with disease progression in chronic HBV infection. 144
Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C. 143
Impact of apolipoprotein E genetic polymorphisms on liver disease: An essential review 143
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 142
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. 142
Vitamin D and the risk of acute allograft rejection following human liver transplantation. 141
IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC. 141
IgM antibody response to the hepatitis C virus core protein in intravenous drug users. 140
Factors associated with serum HCV RNA positivity in anti HCV antibody positive intravenous drug users 140
HUMAN LEUKOCYTE ANTIGEN POLYMORPHISMS IN ITALIAN PRIMARY BILIARY CIRRHOSIS: A MULTICENTER STUDY OF 664 PATIENTS AND 1992 HEALTHY CONTROLS 140
Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation 140
Non-specific increase of serum carbohydrate antigen 19-9 in patients with liver disease associated with increased circulating levels of adhesion molecules. 139
Value of serum C-reactive protein measurement in the detection of hepatocellular carcinoma superimposed on liver cirrhosis 137
Successful minimally invasive management of late portal vein thrombosis after splenectomy due to splenic artery steal syndrome following liver transplantation: a case report 137
Antiviral treatment of hepatitis C 137
Genetic polymorphism at the apolipoprotein E locus affects the outcome of chronic hepatitis B 135
Reliability and reproducibility of the Edmonson grading of hepatocellular carcinoma using paired core biopsy and surgical resection specimens 135
Hepatitis B virus and lymphomagenesis: novel insights into an occult relationship. 134
Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation 134
Antiviral treatment in patients with hepatitis C virus related cirrhosis awaiting liver transplantation 134
Treatment of recurrent genotype 4 hepatitis C after liver transplantation: early virological response is predictive of sustained virological response. An AISF RECOLT-C group study. 133
Increased serum phospholipase A2 activity in advanced chronic liver disease as an expression of the acute phase response. 133
A Multistep, Consensus-Based Approach to Organ Allocation in Liver Transplantation: Toward a "blended Principle Model" 132
Carriage of HFE mutations and outcome of surgical resection for hepatocellular carcinoma in cirrhotic patients 131
Totale 16.357
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.323
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.323
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021641 0 0 0 0 0 0 0 0 0 110 362 169
2021/20221.861 81 149 112 110 27 104 108 97 32 278 479 284
2022/20232.254 259 167 35 304 229 580 1 174 339 25 79 62
2023/2024674 132 78 32 18 138 97 15 33 58 38 10 25
2024/20254.680 100 289 145 172 141 311 304 339 570 361 743 1.205
2025/20267.450 645 923 733 710 1.328 688 945 307 591 580 0 0
Totale 29.837